The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies ...
President Trump has signed an executive order to make certain psychedelic drugs more available to treat mental health ...
President Trump signed an executive order Saturday for a speedy review of psychedelic drugs, including ibogaine.
President Trump signed an executive order on Saturday to make some psychedelic drugs more available to treat mental health ...
Trump ordered faster approval of ibogaine for PTSD, backing research and funding that could expand access to ...
The president issued an executive order increasing research into drugs used to treat PTSD and other disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results